Category Specific RSS

biotech

FDA approves Imugene to commence human trial for lung cancer immunotherapy

Biopharma company Imugene (ASX: IMU) is now on their way towards commercialisation of their lung cancer treatment with approval from…

5 years ago

CLINUVEL to trial new drug addressing irreversible brain damage from by stroke

Leading pharmaceuticals company CLINUVEL (ASX: CUV) is set to commence human trials using the drug afamelanotide to dissolve or remove…

5 years ago

Telix submits FDA application for new prostate cancer imaging product

It may soon be easier for prostate cancer to be diagnosed at an early stage with Telix Pharmaceuticals (ASX: TLX)…

5 years ago

AusCann success with medicinal cannabis for nerve pain trials

Pharmaceuticals company AusCann (ASX: AC8) is set to progress to the next stage of clinical trials having successfully completed their…

5 years ago

Alcidion secures major UK hospital network for Patientrack health monitoring

Smart healthcare continues to make strides in the United Kingdom with healthtech company Alcidion (ASX: ALC) to deploy their Patientrack…

5 years ago

Mayne Pharma strengthens oral contraceptives portfolio in lucrative U.S market

With the increasing competition amongst pharmaceutical companies being driven by a proliferation of generic brands, Mayne Pharma Group (ASX: MYX)…

5 years ago